Sign up or log in to see what your friends are attending and create your own schedule!

View analytic
Filter: Wicklow Hall 2A


Energy that Works: Practical solutions to our energy and climate crisis
    Thursday July 12, 2012 8:00am - 9:30am @ Wicklow Hall 2A

    Fossil fuels are the cornerstone of modern life, but as we face increasing energy demands, decreasing oil reserves, and hazards due to filling our atmosphere with greenhouse gases, it is clear the world is facing an energy crisis. Researchers strive to find solutions, and policy makers and the public are continually presented with 'solutions' that promise the answer. So, what is the answer? Does it lie in renewables or nuclear energy? Perhaps it is in fundamentally changing the way that we live and build our homes? With so many proposed solutions, which ones are practical for the EU?
    Various perspectives will be presented by five experts who have five minutes each to persuade the audience. The audience will then be asked which solution they would support if they had the power to invest in them. The audience will gain an understanding of the difficulties decision makers face in dealing with our Energy and Climate crises.

    The Institute of Energy, Ireland

    National University of Ireland, Galway

    National University of Ireland, Galway

    University of Liverpool, UK

    National University of Ireland, Galway

    National University of Ireland, Galway

    Type Science Programme, Energy Environment & Climate
    Host Organization National University of Ireland, Galway
  • Organiser Sarah Knight
  • Tags SP7


Making gene and cell therapy medicines a reality
    Thursday July 12, 2012 10:45am - 12:15pm @ Wicklow Hall 2A

    The focus of this session will be on outlining the regulatory framework and challenges of translating the exciting basic science discoveries related to molecular and cellular biology into novel, commercial gene and cellular therapies. It aims to bring together leading experts from Regulatory Agencies like EMA and FDA with expert academic and industrial scientists in this area for a fruitful interaction. It also aims to ensure that representatives of patients and those with an ultimate need for these products will be actively included in the meeting in line with an aim of ESOF2012 which is to bring science to the public.

    Irish Medicines Board

    EURODIS – Rare Diseases Europe

    Irish Medicines Board

    Type Science Programme, The Future of Medicine & Health
    Host Organization PDA and IMB
  • Organiser Frank Hallinan
  • Tags SP13


Emerging therapies for brain and retinal diseases
    Thursday July 12, 2012 1:15pm - 2:45pm @ Wicklow Hall 2A

    Diseases of the brain and retina are notoriously difficult to treat. An estimated 98% of EMEA/FDA-approved drugs that could have potential to treat conditions ranging from Alzheimer disease (AD) to Grade IV brain tumours that do not easily cross the blood vessels in the brain and retina. Moreover, as is the case in age-related macular degeneration (AMD), regular and costly injections of therapeutics directly into the globe of the eye carry risks of infection and serious adverse effects.
    Here, we will present information on the emerging therapies that are being developed here in Ireland, Europe and the US with regard to the treatment of debilitating diseases of the retina such as AMD and retinitis pigmentosa (RP). This session aims to inform the public on how emerging medicines are being developed and the promise that these medicines hold for diseases of the brain and retina.

    Duke University, USA

    Beaumont Hospital, Ireland

    Trinity College Dublin, Ireland

    Institute of Ophthalmology, UK

    Type Science Programme, The Future of Medicine & Health
    Host Organization Trinity College Dublin, Ireland
  • Organiser Matthew Campbell
  • Tags SP19


Engaging in a researcher's career in the 21st century
    Thursday July 12, 2012 4:00pm - 5:30pm @ Wicklow Hall 2A

    Research, especially in Europe, never offered so many opportunities as nowadays. However, the competition for rewarding careers has never been so fierce. The economic austerity is also affecting research funding and career opportunities in some countries. As a consequence, whereas it may be exciting to engage in a research career it carries risk like research itself.

    In this session panellists will share their perception on the challenges for a scientist engaging in a research career nowadays. They will also provide clues on what they believe are the ingredients to a successful career (legal environment, education, international mobility, good networking opportunities, interdisciplinary, collaboration with businesses, pathways from academia to business, and passion for science…).

    Through their experiences, the former Marie Curie fellows will explain how the mobility fellowship helped develop their career. Each of the panellists' profiles illustrates how mobility and training can contribute to a successful career.


    Dr Anil Kokaram is a professor at Trinity College and Entrepreneur...

    Research Director, Irish Universities Association

    Marie Curie Fellow, Adviser to the President of Romania

    University of Namur, Belgium

    Trinity College Dublin, Ireland

    Cambridge Centre for Gallium Nitride, University of Cambridge...

    Type Careers Programme
    Host Organization European Commission DG EAC
    Tags CP6



Beyond the Arab Spring: science and innovation in the Islamic world
    Friday July 13, 2012 8:00am - 9:30am @ Wicklow Hall 2A

    As the wider world watches the social and political shifts in the wake of the Arab Spring, the scientific community is looking to the rapid developments in the science, technology and innovation sectors in the Islamic countries of the Middle East and beyond. Countries such as Saudi Arabia and Qatar are pouring natural resource wealth into universities and technology parks. But it is not just hydrocarbon-rich countries that are striving to make the move towards knowledge-based economies. Pakistan established over 50 new universities between 2002 and 2008. In Egypt, the new Library of Alexandria is an example of a world-class teaching and research institution that has developed independently of the university system.
    The Atlas of Islamic World Science and Innovation Project is being coordinated by a unique collection of international partners and is examining the past and future of the STI systems of Islamic countries. This is a time of rapid development in modern science and one that presents many opportunities to establish new and fruitful international collaborations for Europe and the rest of the world.

    Research Fortnight/Research Europe, UK

     Freelance science writer, UK

     Freelance science journalist and blogger (Science Safari...

    Type Science Programme, Policy
    Host Organization Royal Society of London
  • Organiser Luke Clarke
  • Tags SP25


Science without borders
    Friday July 13, 2012 10:45am - 12:15pm @ Wicklow Hall 2A

    This session is designed to identify best practices and pitfalls encountered by different countries when practicing science without borders. The high-level international speakers will bring unique insights into the science behind science policy making, implementation and evaluation. Climate change, energy and resource efficiency, health and demographic change, food security and the digital divide, are opportunities for research and innovation, which will help us to create the necessary jobs and wealth to take the developed and developing world out of the current economic crisis, achieving sustainable development and alleviating poverty.

    An important focus will be on Africa's determination to not only harness science and technology for the continent's development, but to become a full and active partner in global knowledge partnerships. Progress on the roadmap towards a true European Innovation Union with dynamic international cooperation links will be assessed. The imperative of re-focusing R&D and innovation policy on the challenges facing our global society from the American and Asian perspectives will also be tackled.

    American Association for the Advancement of Science, USA

    Joint Research Centre of the European Commission

    Minister of Science and Technology, Republic of South Africa...

    Secretary-General of the Association of Commonwealth Univers...

    Chief Science Advisor to the Prime Minister, New Zealand...

    Type Science Programme, Policy
    Host Organization South African Department of Science and Technology
  • Organiser Daan Du Toit
  • Tags SP34


Is collaboration with Russia vitally important for Europe?


Is science driven policy making an achievable goal?
    Friday July 13, 2012 4:00pm - 5:30pm @ Wicklow Hall 2A

    Evidence based policy making is increasingly important, as policy makers are faced with policy dilemmas and need scientific input for policy development. Recent emergencies with a serious public impact (volcanic eruptions in Europe, earthquake and tsunami in Japan etc.) have shown that we need to speed up the interaction between science and politics in urgent situations. The purpose of the session would be to address via interactive discussions how to bring science even closer to policy making, what are the main challenges, and to share experiences and compare different systems in the EU and the US.

    Joint Research Centre of the European Commission

    Rathenau Instituut, The Netherlands

    Member of the European Parliament, UK

    Member of the European Parliament, Austria

    Government Accountability Office, USA

    Type Science Programme, Policy
    Host Organization STOA, European Parliament
  • Organiser Theodoros Karapiperis
  • Tags SP46



Tomorrow's vaccines today
    Saturday July 14, 2012 8:00am - 9:30am @ Wicklow Hall 2A

    The world in the 21st century is faced with a myriad of global health problems which can only be solved by scientific cooperation and subsequent breakthroughs. It is therefore crucial to coordinate efforts in research, education and funding to foster an enabling environment in which out-of-the-box thinking is encouraged and innovation can deliver products.
    The European vaccine research field serves as the ultimate example. The main knowledge gap within vaccine research is the lack of understanding of the immunological mechanisms mediating protection. In order to deliver the vaccines of tomorrow, the field needs to re-engineer its thinking and endorse an innovation fostering, long term vision for vaccine design and immunology.
    The interdependencies of the policy areas for vaccinology are a general example of how inter-agency cooperation must be promoted to achieve success, which will guarantee access to knowledge, and will ultimately contribute to efficiency, better jobs and new products, such as innovative vaccines.

    Themis Bioscience GmbH, Austria

    Director, Vaccine Research, Merck Research Laboratories, US...

    Université Pierre et Marie Curie, France

    European Vaccine Initiative, Germany

    Type Science Programme, The Future of Medicine & Health
    Host Organization European Vaccine Initiative
  • Organiser Regitze Louise Thøgersen
  • Tags SP53


Can Europe save the pharma industry?
    Saturday July 14, 2012 9:30am - 10:45am @ Wicklow Hall 2A

    The combination of greater longevity and some bad lifestyle choices in the developed world are resulting in an increasing incidence of a wide range of chronic ailments including diabetes, cancer and neuro-degenerative diseases. This results in a growing demand for drugs as well as presenting new targets for drug development. Yet despite this positive market outlook the global pharma industry is facing an existential crisis. The causes/symptoms of this crisis have been well-rehearsed: expiration of patents for blockbuster drugs, escalating development costs and shrinking development pipeline; these factors are exacerbated by governmental pressure to reduce expenditure on public drug purchase schemes.

    This session will explore how to rekindle innovation in the pharma industry and in particular how Europe can take the lead in getting the industry on a viable path?Specific questions to be addressed include:

    • What actions are required of industry, universities, funding agencies and the European Commission?
    • To what extent will new technologies (genomics, proteomics, in silico development, personalised medicine and diagnostics) help? Who should pay the associated costs?
    • Can new ways of collaboration be a solution? 
    • How can regulatory burden be minimised without compromising patient safety (up to 45,000 patients in phase III trial)?
    • Is IMI a solution/a path forward?

    Company Group Chairman, Johnson & Johnson Pharmaceuticals   Jaak...

    Trinity College Dublin, Ireland Chairman of the ESOF2012 Programme...

    Director General, Science Foundation Ireland

    Cabinet member in the office of Máire Geoghegan-Quinn, European...

    Type Science Programme, The Future of Medicine & Health
    Host Organization ESOF2012
  • Organiser Eamonn Cahill
  • Tags SP57


Open science - best practice in sharing the research process with the public
    Saturday July 14, 2012 10:45am - 12:15pm @ Wicklow Hall 2A

    More than ever it is important for society to comprehend the processes of science. Science is all around us, and our communal past is being studied and our future developed in research laboratories. It is vital that the general public be given the opportunity to comprehend the aspects of science and technology that affect our daily lives. But how is it possible to give lay people an insight into the processes and methods of today's research? How much of scientific content and concepts can be conveyed? How can the public be enabled to participate in the scientific process?
    In this session five speakers will introduce their institutions' individual approach for bringing science to the public. They come from museums and science centres as well as from the research community and share a wide experience of effective and innovative methods of communicating science in their fields and providing the public access even to cutting edge research. Speakers will define their positions on boundary conditions for developing an effective dialogue on science between public and researchers and also the limits of this endeavour. In addition, they will discuss the degree of scientific literacy that can be developed in the dialogue between researchers and the public and how scientific culture in society can be promoted.

    Science Gallery, Ireland   Since 2006 Lynn Scarff has been...

    Naturalis - National Museum of Natural History, Netherlands

    Technische Universitaet Dresden, Germany

    Deutsches Museum, Germany

    Fermilab, CERN, Switzerland

    Type Science Programme, Engagement & Education
    Host Organization Technische Universitaet Dresden
  • Organiser Paul Hix
  • Tags SP61


Stem cells in personalised medicine
    Saturday July 14, 2012 1:15pm - 2:45pm @ Wicklow Hall 2A

    The International Cell Research Organization (ICRO-UNESCO) is promoting high level education especially in the developing word. This workshop intends to review promising human stem cell applications in medical therapy as well as in pharmacological and toxicological screenings, focusing on implications in personalised medicine.

    Human stem cells provide an important novel tool for personalized medical treatments and for generating pharmacological and toxicological test systems. In the development of new targeted therapies, as well as in critical safety issues, animal based tests are mostly unsatisfactory, whereas the use of in vitro model systems is limited by the unavailability of relevant human tissues. Human embryonic stem cell lines may fill this gap, and offer an advantage over primary cultures as well as tissue-derived (adult) stem cells.

    Hungarian Academy of Sciences, Hungary

    University of Pittsburg, USA

    University of Cambridge, UK

    Catholic University of Leuven, Belgium

    Type Science Programme, The Future of Medicine & Health
    Host Organization Hungarian Academy of Sciences
  • Organiser Balazs Sarkadi
  • Tags SP68


Are science journalists doing their job?
    Saturday July 14, 2012 4:00pm - 5:30pm @ Wicklow Hall 2A

    Across the world governments are investing heavily in science and technology to increase prosperity and benefit their societies. But this capacity building needs proper scrutiny to ensure that public and private money is spent well and to enhance rather than diminish our quality of life. We bring together three of the world's leading science journalists to discuss how they stopped science going wrong in their countries. They are Pallava Bagla from India who exposed the grey literature used in climate change and Veronique Morin a documentary maker and TV presenter on the exploitation of native Canadians for scientific research.

    Australian Broadcasting Corporation

    Science magazine; New Delhi Television, India

    Tele-Quebec, Canada

    Type Science Programme, Communicating Science
    Host Organization SciCom - Making Sense of Science
  • Organiser Aidan Gilligan
  • Tags SP69



Probiotics: alternative medicine or an evidence-based alternative?
    Sunday July 15, 2012 8:00am - 9:30am @ Wicklow Hall 2A

    From a scientific standpoint, probiotics are defined as bacteria which, when consumed in adequate amounts, confer a health benefit on the host. But ‘probiotic’ is also a marketing term which has become very familiar to the general public as a result of polished advertising campaigns, which are all too often littered with vague health claims based on anecdotal or poorly conducted research, if indeed, any research at all.

    It is difficult for any consumer to discriminate between those few probiotic strains for which there is rigorous scientific data supporting specific health benefits in humans, and those which are simply members of a ‘probiotic’ genus such as Bifidobacterium or Lactobacillus.

    This workshop will involve scientists highlighting some of the best evidence to support a role for probiotics in human health, detaching scientific rigour from marketing hype.

    Alimentary Pharmabiotic Centre, University College Cork, Ire...

    Wageningen Centre for Food Sciences, Wageningen University, The...

    Teagasc, Ireland

    Alimentary Pharmabiotic Centre, University College Cork, Ire...

    Type Science Programme, The Future of Medicine & Health
    Host Organization University College Cork, Ireland
  • Organiser Colin Hill
  • Tags SP79


Ageing in Europe: Abyss or opportunity?
    Sunday July 15, 2012 1:15pm - 2:45pm @ Wicklow Hall 2A

    Health and welfare varies enormously between European nations and nations globally. Simultaneously, common challenges are easily identified. From a public health perspective, aging is an overarching phenomenon in many countries. Welfare systems, to the extent they at all exist, should be robust enough to provide sustainable solutions to create a balance between generations. A healthier population seems imperative if a postponed retirement age is required.
    In this panel discussion, research in demography, public health, prevention, harm reduction, harm assessment, and policy will be discussed. A pressing general societal issue is the distribution of health and welfare, which tend to exhibit a social gradient. Health and welfare as critical features of societal cohesion and as potential sources of severe threats to cohesion are evident in the perspective of their distribution in populations. The discussion will be focused on questions such as ‘How can basic research in different fields serve as a basis for policy and politics?’ and ‘How can advances in research contribute to individual and societal benefits?’.

    Imperial College London, UK

    University of Tartu, Estonia

    Karolinska Institute, Sweden

    University of Helsinki, Finland

    Type Science Programme, The Future of Medicine & Health
    Host Organization Swedish Council for Working Life and Social Research
  • Organiser Erland Hjelmquist
  • Tags SP86


Share on
Facebook Twitter
Take A Tour Of Site Features

Get Adobe Flash player